Polymyositis and dermatomyositis: Difference between revisions
No edit summary |
No edit summary |
||
Line 5: | Line 5: | ||
{{CMG}}; {{AE}} {{SSH}} | {{CMG}}; {{AE}} {{SSH}} | ||
{{SK}} | {{SK}}Polymyositis, dermatomyositis, PMDM, DMPM, dermatomyositis and polymyositis | ||
==[[Polymyositis and dermatomyositis overview|Overview]]== | ==[[Polymyositis and dermatomyositis overview|Overview]]== |
Revision as of 14:58, 18 April 2018
Polymyositis and dermatomyositis Microchapters |
Differentiating Polymyositis and dermatomyositis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Polymyositis and dermatomyositis On the Web |
American Roentgen Ray Society Images of Polymyositis and dermatomyositis |
Risk calculators and risk factors for Polymyositis and dermatomyositis |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Synonyms and keywords:Polymyositis, dermatomyositis, PMDM, DMPM, dermatomyositis and polymyositis
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Polymyositis and dermatomyositis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies